A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)

Condition:   Polycystic Ovary Syndrome (PCOS) Interventions:   Drug: Placebo;   Drug: Pioglitazone;   Drug: Spironolactone;   Drug: Metformin Sponsor:   Fundació Sant Joan de Déu Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials